InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: frrol post# 118283

Saturday, 09/02/2017 10:27:33 AM

Saturday, September 02, 2017 10:27:33 AM

Post# of 460346

Dr Missling acknowledged at the AGM that the company has no research showing superiority of our compounds over other known S1 agonists (eg donepezil), and that this was an issue



This is not a true statement. (I was there) He stated there was no difference in the effectiveness of 273 with or without dionepezil. But 273 was effective.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News